Jaguar Health's 816% Revenue Surge Fuels Plant-Based Rare Disease Drug Development

San Francisco, Thursday, 28 May 2026.
Driven by an 816% revenue surge from a strategic licensing deal, Jaguar Health is accelerating the development of its unique plant-derived drug for rare and severe intestinal disorders.